Making cell-free DNA testing accessible to all healthcare providers

News & Update

Gene Solutions divider

Get the latest news and updates of our company and medical field.

No data found

Our Tests

Gene Solutions divider

01

Reproductive Health

triSure

Unique NIPT test provider that integrates mothers' carrier screening (Thalassemia included) in one single blood draw.

Most popular & accessible, >1M tests performed, highly sensitive cell-free DNA assay that significantly reduces invasive diagnostics procedure & informs OB-GYNs for clinical utility.(1)

(1) Minh-Duy Phan, “Establishing and validating noninvasive prenatal testing procedure for fetal aneuploidies in Vietnam” (The Journal of Maternal-Fetal & Neonatal Medicine, 2018)
triSure Procare

NIPT with de novo mutations (7,000 mutations screened for 25 common single-gene disorders(2))

Most comprehensive NIPT option for high-risks pregnant women (>35 years old / having abnormal ultrasound findings / family history with investigated conditions)

(2) ACMG, Practice guideline, June 2008

02

Clinical Oncology

K-Track

Personalized minimal residual disease (MRD) assay using patients' circulating tumor DNA and tumor profiling.(3)

With options to cover targeted actionable mutations, germline mutations, microsatellite instability (MSI) for 09 types of cancers or metastatic stage

(3) Lan N Tu, ”Personalized K-Track assay to detect actionable mutations and minimal residual disease in solid tumors.” (ASCO Publications, JCO Global Oncology, 2023).
SPOT-MAS

Multi-cancers early detection (MCED) test for healthy individuals above 40 years old.

Region's largest clinical validation for multimodal analysis in plasma cell-free DNA to detect signal of circulating tumor DNA and predict tumor location.(4)

(4) L.S. Tran, “Clinical validation of a ctDNA-based assay for multi-cancer detection: An interim report from a Vietnamese longitudinal prospective cohort study of 2795 participants.” (ASCO Publications, JCO Global Oncology, 2023)

Our Markets

Gene Solutions divider

Discover our world-wide markets

Pioneer
in research,
development and application of

Next Generation
Sequencing
For clinical
utility
The total number of tests performed is
0+
(As of )
Tests Performed for pregnancy care
0+

Tests Performed for pregnancy care

Tests Performed for cancer screening
0+

Tests Performed for cancer screening

Partnered hospitals/clinics using Gene Solution tests
0+

Partnered hospitals/clinics using Gene Solution tests

Peer-reviewed publications
0+

Peer-reviewed publications

Clinical Resources

It is our duty as science endorsers and medical practitioners to bring about the benefits of cell-free DNA innovation to improve the healthcare system.

Find out our peer-reviewed publications, awarded posters, technical information… or send a contact request for research connection.

Clinical Resources